(Q51787809)

12 April 2018

title

Prion safety of transfusion plasma and plasma-derivatives typically used for prophylactic treatment. (English)

1 reference

12 April 2018

0 references

3

1 reference

12 April 2018

author name string

Tor-Einar Svae

1

1 reference

12 April 2018

Andrea Neisser-Svae

2

1 reference

12 April 2018

Herwig Reichl

4

1 reference

12 April 2018

Lothar Biesert

5

1 reference

12 April 2018

Torben Schmidt

6

1 reference

12 April 2018

Andrea Heger

7

1 reference

12 April 2018

Jürgen Römisch

8

1 reference

12 April 2018

publication date

10 July 2008

1 reference

12 April 2018

Transfusion and Apheresis Science

published in

1 reference

12 April 2018

volume

39

1 reference

12 April 2018

issue

1

1 reference

12 April 2018

page(s)

59-67

1 reference

12 April 2018

Prions: properties, occurrence, modes of transmission and relevance for blood transfusion and blood derivatives

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Deaths from variant Creutzfeldt-Jakob disease in the UK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

American fresh frozen plasma for neonates and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Brain and buffy coat transmission of bovine spongiform encephalopathy to the primate Microcebus murinus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Transmission of prion diseases by blood transfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Preliminary assessment of whole-blood, red-cell and platelet- leucodepleting filters for possible induction of prion release by leucocyte fragmentation during room temperature processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Technical aspects of the development and validation of tests for variant Creutzfeldt-Jakob disease in blood transfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Blood infectivity, processing and screening tests in transmissible spongiform encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Creutzfeldt-Jakob disease: recommendations for disinfection and sterilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Removal of TSE agents from blood products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

A matter for debate: the risk of bovine spongiform encephalopathy to humans posed by blood transfusion in the UK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Prevalence of lymphoreticular prion protein accumulation in UK tissue samples.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Partitioning of human and sheep forms of the pathogenic prion protein during the purification of therapeutic proteins from human plasma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

High incidence of scrapie induced by repeated injections of subinfectious prion doses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Implications of BSE infection screening data for the scale of the British BSE epidemic and current European infection levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Modelling the epidemic of variant Creutzfeldt-Jakob disease in the UK based on age characteristics: updated, detailed analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Purity of spiking agent affects partitioning of prions in plasma protein purification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Partitioning of TSE infectivity during ethanol fractionation of human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Distribution of a bovine spongiform encephalopathy-derived agent over ion-exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Prion-removal capacity of chromatographic and ethanol precipitation steps used in the production of albumin and immunoglobulins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Studies on the removal of a bovine spongiform encephalopathy-derived agent by processes used in the manufacture of human immunoglobulin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Evaluation of depth filtration to remove prion challenge from an immune globulin preparation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Variant CJD transmission through blood: risks to predictors and "predictees"

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

Population-based audit of fresh-frozen plasma transfusion practices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2008.05.006

10.1016/J.TRANSCI.2008.05.006

7 January 2021

Identifiers

DOI

1 reference

12 April 2018

PubMed ID

18619902

1 reference

12 April 2018